BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28415594)

  • 1. Interaction of Epstein-Barr virus genes with human gastric carcinoma transcriptome.
    Zhang R; Strong MJ; Baddoo M; Lin Z; Wang YP; Flemington EK; Liu YZ
    Oncotarget; 2017 Jun; 8(24):38399-38412. PubMed ID: 28415594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognizing the role of Epstein-Barr virus in gastric cancer: transcriptomic insights into malignancy modulation.
    Anbouhi TS; Sazegar H; Rahimi E
    Virol J; 2024 Feb; 21(1):41. PubMed ID: 38355581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
    Li W; Okabe A; Usui G; Fukuyo M; Matsusaka K; Rahmutulla B; Mano Y; Hoshii T; Funata S; Hiura N; Fukayama M; Tan P; Ushiku T; Kaneda A
    Cancer Sci; 2021 Aug; 112(8):3349-3362. PubMed ID: 34014591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.
    Borozan I; Zapatka M; Frappier L; Ferretti V
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
    Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
    World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma.
    Fukayama M; Hino R; Uozaki H
    Cancer Sci; 2008 Sep; 99(9):1726-33. PubMed ID: 18616681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and gastric carcinoma.
    Fukayama M
    Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
    Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
    Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors.
    Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
    Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
    Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
    Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
    Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer.
    Zhu M; Liang Q; Chen T; Kong Q; Ye G; Yu S; Li X; He Q; Liu H; Hu Y; Yu J; Li G
    Clin Epigenetics; 2021 Jan; 13(1):22. PubMed ID: 33514440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the key genes of Epstein-Barr virus-regulated tumour immune microenvironment of gastric carcinomas.
    Zhou H; Jing S; Liu Y; Wang X; Duan X; Xiong W; Li R; Peng Y; Ai Y; Fu D; Wang H; Zhu Y; Zeng Z; He Y; Ye Q
    Cell Prolif; 2023 Mar; 56(3):e13373. PubMed ID: 36519208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
    Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
    Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.
    Nakano H; Saito M; Nakajima S; Saito K; Nakayama Y; Kase K; Yamada L; Kanke Y; Hanayama H; Onozawa H; Okayama H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Goto A; Kono K
    Sci Rep; 2021 Jan; 11(1):1982. PubMed ID: 33479394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk to the gastric corpus in Japanese, its correlation with interleukin-1beta gene polymorphism (+3953*T) and Epstein-Barr virus infection.
    Sakuma K; Uozaki H; Chong JM; Hironaka M; Sudo M; Ushiku T; Nagai H; Fukayama M
    Int J Cancer; 2005 May; 115(1):93-7. PubMed ID: 15688413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
    Strong MJ; Xu G; Coco J; Baribault C; Vinay DS; Lacey MR; Strong AL; Lehman TA; Seddon MB; Lin Z; Concha M; Baddoo M; Ferris M; Swan KF; Sullivan DE; Burow ME; Taylor CM; Flemington EK
    PLoS Pathog; 2013; 9(5):e1003341. PubMed ID: 23671415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.
    Shinozaki-Ushiku A; Kunita A; Isogai M; Hibiya T; Ushiku T; Takada K; Fukayama M
    J Virol; 2015 May; 89(10):5581-91. PubMed ID: 25740983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
    Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.